HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia by Small H. et al.
Physiological Genomics 2017 vol.49 N3, pages 193-200
HLA gene expression is altered in whole blood and
placenta from women who later developed preeclampsia
Small H., Akehurst C., Sharafetdinova L., McBride M., McClure J., Robinson S., Carty D., Freeman
D., Delles C.
Kazan Federal University, 420008, Kremlevskaya 18, Kazan, Russia
Abstract
© The American Physiological Society. Preeclampsia is a multisystem disease that significantly
contributes to maternal and fetal morbidity and mortality. In this study, we used a non-biased
microarray approach to identify dysregulated genes in maternal whole blood samples which
may be associated with the development of preeclampsia. Whole blood samples were obtained
at 28 wk of gestation from 5 women who later developed preeclampsia (cases) and 10 matched
women with normotensive pregnancies (controls).  Placenta samples were obtained from an
independent cohort of 19 women with preeclampsia matched with 19 women with normotensive
pregnancies.  We  studied  gene  expression  profiles  using  Illumina  microarray  in  blood  and
validated changes in gene expression in whole blood and placenta tissue by qPCR. We found a
transcriptional  profile  differentiating  cases  from  controls;  336  genes  were  significantly
dysregulated in  blood from women who developed preeclampsia.  Functional  annotation  of
microarray results indicated that most of the genes found to be dysregulated were involved in
inflammatory pathways. While general trends were preserved, only HLA-A was validated in
whole blood samples from cases using qPCR (2.30-± 0.9-fold change) whereas in placental
tissue HLA-DRB1 expression was found to be significantly increased in samples from women
with preeclampsia (5.88-± 2.24-fold change). We have identified that HLA-A is upregulated in
the circulation of women who went on to develop preeclampsia. In placenta of women with
preeclampsia we identified that HLA-DRB1 is upregulated. Our data provide further evidence for
involvement of the HLA gene family in the pathogenesis of preeclampsia.
http://dx.doi.org/10.1152/physiolgenomics.00106.2016
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